These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 11156404
1. Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model. Zuckier LS, Berkowitz EZ, Sattenberg RJ, Zhao QH, Deng HF, Scharff MD. Cancer Res; 2000 Dec 15; 60(24):7008-13. PubMed ID: 11156404 [Abstract] [Full Text] [Related]
2. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL. Cancer Res; 1992 Jan 15; 52(2):377-84. PubMed ID: 1728409 [Abstract] [Full Text] [Related]
3. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. Wang X, Campoli M, Ko E, Luo W, Ferrone S. J Immunol Methods; 2004 Nov 15; 294(1-2):23-35. PubMed ID: 15604013 [Abstract] [Full Text] [Related]
5. Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results. Le Doussal JM, Barbet J, Delaage M. Int J Cancer Suppl; 1992 Nov 15; 7():58-62. PubMed ID: 1428406 [Abstract] [Full Text] [Related]
6. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen. Kang N, Hamilton S, Odili J, Wilson G, Kupsch J. Clin Cancer Res; 2000 Dec 15; 6(12):4921-31. PubMed ID: 11156253 [Abstract] [Full Text] [Related]
10. Improved tumor targeting by combined use of two antitenascin antibodies. Petronzelli F, Pelliccia A, Anastasi AM, D'Alessio V, Albertoni C, Rosi A, Leoni B, De Angelis C, Paganelli G, Palombo G, Dani M, Carminati P, De Santis R. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813 [Abstract] [Full Text] [Related]
11. Targeting behavior of rat monoclonal IgG antibodies in vivo: role of antibody isotype, specificity and the target cell antigen density. Yousaf N, Howard JC, Williams BD. Eur J Immunol; 1991 Apr 01; 21(4):943-50. PubMed ID: 2019290 [Abstract] [Full Text] [Related]
15. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency. Scallon B, Cai A, Radewonuk J, Naso M. Mol Immunol; 2004 May 15; 41(1):73-80. PubMed ID: 15140577 [Abstract] [Full Text] [Related]
16. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Juweid M, Neumann R, Paik C, Perez-Bacete MJ, Sato J, van Osdol W, Weinstein JN. Cancer Res; 1992 Oct 01; 52(19):5144-53. PubMed ID: 1327501 [Abstract] [Full Text] [Related]